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Abstract
The right ventricular (RV) apex has been the standard pacing site since the development of 
implantable  pacemaker  technology.  Although RV pacing was initially  only  utilized  for  the 
treatment of severe bradyarrhythmias usually due to complete heart block, today the indications 
for and implantation of RV pacing devices is dramatically larger.  Recently, the adverse effects 
of chronic RV apical pacing have been described including an increased risk of heart failure 
and death.  This review details  the detrimental effects  of RV apical pacing and their  shared 
hemodynamic pathophysiology. In particular, the role of RV apical pacing induced ventricular 
dyssynchrony is highlighted with a specific  focus on differential  outcome based upon QRS 
morphology at implant.
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Introduction
The development  of implantable pacemaker  technology in the mid 20th century proved life 
saving for many patients with bradyarrhythmias [1]. In the intervening decades the indications 
for and volumes of permanent pacemaker placement have expanded [2-4] concurrent with a 
geographically  dependent  aging  population.  Right  ventricular  (RV)  apical  lead  placement 
rapidly became standard practice secondary to the ease of site accessibility and lead stability. In 
most situations, RV apical pacing is effective and well tolerated.                                    
However, an increasing amount of data has recently raised questions about the safety of RV 
apical pacing [5-14]. These safety concerns arise from the suggestion that RV apical pacing 
may have detrimental effects on cardiac structure and left ventricular (LV) function [15-17]. 
This  is  likely the result  of the pathologic abnormal electrical  and directly  related abnormal 
mechanical  activation  of  the  ventricles  seen  as  a  consequence  of  RV  apical  pacing.  An 
understanding of this pathophysiology has driven the development of pacing technology to limit 
the need for right ventricular apical pacing and the search for improved methods of ventricular 
pacing.
This review details the detrimental effects of RV apical pacing and its associated hemodynamic 
pathophysiology. In particular, the role of RV apical pacing induced ventricular dyssynchrony 
is  highlighted  with  specific  focus  on  differential  outcome based upon QRS morphology at 
implant. Alternative and developing  pacing  strategies  for  patients  with  a  permanent  pacing 
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indication including cardiac resynchronization therapy (CRT), alternative pacing sites, leads, 
programming configurations and energy sources are also discussed.                                          
RV Apical  Pacing and Outcome: Clinical  Data                                          
For decades, RV apical pacing proved to be an effective therapy for sinus node disease [11], 
atrio-ventricular (AV) block [10], drug-refractory atrial fibrillation [18] and some forms of LV 
dysfunction  [19].  A  number  of  randomized  studies  have  focused  on  the  optimal  pacing 
configuration and mode dependent on the pacing indication [6,10-14]. In addition to answering 
their intended questions, these studies have also shed light, although often indirectly, on the 
association  between  RV  apical  pacing  and  adverse  cardiovascular  outcome.             
Deleterious effects of RV apical pacing: Pacemaker Studies                                 
Studies that have shown the deleterious effects of RV apical pacing can be categorized by the 
indication of pacemaker implantation and by the mode of pacing. Studies enrolling patients 
with sinus node dysfunction compared VVI with AAI pacing or DDD with AAI pacing whereas 
those  enrolling  patients  with  AV block  compared  the  effects  of  DDD with  VVI  pacing.  
Andersen et  al  [5] investigated 225 patients  with sinus node dysfunction (SND), through a 
comparison of VVI to AAI pacing and found significantly  higher  cardiovascular  mortality, 
incidence of heart failure (HF) and NYHA functional class in the ventricular pacemaker group. 
Several clinical studies [14,20-22] in SND patients displayed that DDD pacing compared to 
AAI pacing induces left atrial dilation and, in the case of a high proportion of RV pacing, also 
reduces  LV  function,  myocardial  relaxation  and  myocardial  blood  flow.  The  DANPACE 
(Danish Multicenter Randomized Study on AAI Versus DDD Pacing in SND) study [13-14] 
was designed to prospectively determine if atrial pacing is superior to dual chamber pacing. 
DANPACE  randomized  177  patients  with  isolated  SND  (without  any  significant  atrio-
ventricular conduction disturbance) to one of three pacing modes: AAIR, DDDR with a short 
atrio-ventricular (AV) delay (110–150 ms) and DDDR with a long atrio-ventricular delay (>250 
ms).  As expected,  there was a  significant  difference  in  the frequency of  ventricular  pacing 
between  modes:  AAIR  (0%),  DDDR  long  AV  (17%)  and  DDDR-short  AV  (90%).  This 
programming dependent increase in frequency of RV pacing was associated with an unadjusted 
increased risk of atrial  fibrillation (AF) and stroke.  The risk for AF was lowest with atrial  
pacing:  AAIR  (3% per  year),  followed  by  DDDR-long  (8.2% per  year)  and  DDDR-short 
(11.7% per year), and there was a trend for fewer thrombo-embolic events with atrial pacing: 
AAIR (1.9% per year), followed by DDDR-long (2.2% per year) and DDDR-short (4.0% per 
year)  [14].                                             
Providing a possible mechanism for the increase in both endpoints, Nielsen et al. demonstrated 
that  the  use  of  dual-chamber  pacing  (i.e.  high  RV  pacing)  is  associated  with  left  atrial 
enlargement  when  compared  to  atrial  pacing  alone  [14].  This  suggests  that  one  of  the 
deleterious  effects  of  right  ventricular  pacing may be increased atrial  pressure,  resulting  in 
structural  atrial  remodeling  and increased risk of AF.                                     
Several studies of DDD vs. VVI only pacing in patients with AV block [10] [11], or both AV 
block and SND [12], generated the hypothesis that RV apical pacing may be detrimental (Table 
1).  The expectation  was that  DDD pacing would be beneficial  over  RV apical  only (VVI) 
pacing secondary to maintenance of AV synchrony, resulting in a reduction in heart  failure 
(HF), cardiovascular mortality, AF and stroke. Within these studies, only AF was significantly 
reduced  with  DDD  pacing  leaving  questions  regarding  the  importance  of  maintaining  AV 
synchrony on heart failure and mortality.     
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Table 1: Pacing and ICD studies examining RV pacing and Outcome
      
A subsequent subgroup analysis of MOST (MOde Selection Trial) among patients with QRS 
<120 msec shed light on a possible underlying reason for the negative outcomes of these studies 
[11]. It demonstrated a strong association between RV pacing and the risk of HF events and AF 
in both DDD (mean 90% RV pacing burden, n = 707) and VVI pacing (mean 50% RV pacing 
burden, n = 632) groups. More specifically, patients with greater than 40% of ventricular pacing 
burden in the DDD group and >80% of ventricular pacing in the VVI pacing group had more 
than  two  fold  increased  risk  for  HF  events  (DDD  adjusted  hazard  ratio  (HR):  2.60;  95% 
confidence interval (CI): 1.05 to 6.47; p < 0.05; VVI HR: 2.50; 95% CI: 1.44 to 4.36; p < 0.05).  
Similarly, each 25% increase in RV pacing burden was associated with an approximate mean 
increase of 28% (adjusted 36% for DDD and 21% for VVI only) in AF. The similar increase in 
HF  and  AF  with  DDD and  VVI  only  pacing  supports  the  notion  that  maintenance  of  AV 
synchrony  does  not  convey  a  risk  reduction  in  either.  Rather,  the  RV apical  pacing  burden 
outweighed any benefit of AV synchrony in the DDD group and was the primary driver behind 
the negative trial  result.  Freudenberger  et  al,  [23] examining more than 11,000 patients who 
underwent pacemaker implantation, found that permanent dual chamber or ventricular pacing in 
patients  who did  not  have  HF before  implantation,  significantly  increased  their  risk  for  HF 
hospitalizations or HF-related deaths compared with matched control group.                        
Deleterious effects of RV apical pacing: Defibrillator Studies                                  
The  DAVID  (Dual  Chamber  and  Implantable  Defibrillator)  trial  further  substantiated  the 
association  between  RV pacing  and  adverse  cardiovascular  outcome [6].  Operating  with  the 
hypothesis  that  DDD  pacing  will  convey  a  reduction  in  HF,  506  patients  with  a  standard 
indication for ICD implant and no indication for pacing were randomized to "physiologic pacing" 
ICD with DDD backup heart rate 70 (DDD -70) vs. single chamber ICD with VVIR backup heart 
rate 40 (VVI - 40). After one year follow up, the combined endpoint of hospitalization for HF or 
death was significantly higher for the DDD - 70 group (26.7%) compared to the VVI - 40 group 
(16.1%) with an adjusted HR of 1.61 (95% CI 1.06-2.44, p = 0.03). The difference in the backup 
rate between the two groups resulted in a marked difference in the burden of RV pacing with 
DDD - 70 patients paced 60% of the time and VVI - 40 patients just 3% of the time. Congruent 
with  findings  from MOST,  an RV pacing dose dependent  positive relationship with  adverse 
cardiovascular  events  was  noted.                                             
The  MADIT  II  (Multicenter  Automated  Defibrillator  Implantation  Trial  II)  enrolled  1,232 
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patients with ischemic cardiomyopathy randomized to ICD vs. medical therapy in a 3:2 ratio. 
ICD configurations within the study included single chamber programmed VVI-40 (44%) and 
dual chamber programmed DDD-70 (56%). Steinberg et al reported the short term (median 1.5 
years) follow up of RV pacing in the ICD arm dichotomized by a pacing burden of greater (high 
RV pacing) and less than 50% (low RV pacing) [8]. Patients with high RV pacing were older,  
had  higher  blood urea  nitrogen  levels,  and were  more  likely to  have  wide QRS and LBBB 
compared with non-ICD patients or patients with low RV pacing. After multivariate adjustment, 
high RV pacing patients were at significantly increased risk of new or worsened HF (HR 1.93, p 
= 0.002) and appropriate ICD therapy for VT/VF (HR 1.50, p = 0.02). However, the mortality 
rates were similar for high (13%) and low (10%) RV pacing groups (adjusted HR 1.07, p = 0.78) 
[8].  
Most  recently,  we have analyzed  the  association between percent  RV pacing and long term 
mortality  in  MADIT II  during  an 8-year  follow-up [9].  Patients  were  categorized  into  three 
subgroups: low RV pacing (< 50% pacing, n = 369), high RV pacing (≥ 50% pacing, n = 198), 
and no ICD (n = 490). During the first  3 years after enrollment, the benefit  of the ICD was 
prominent  both  in  patients  with  low  RV  pacing  (adjusted  65%  reduction  in  risk  of  death, 
P<0.001) and in those with high RV pacing (adjusted 62% reduction in risk of death, P<0.001); 
In contrast, during the late phase of the extended follow-up period (4-8 years) ICD therapy was 
associated with a significant  survival benefit  among patients in the low RV pacing subgroup 
(adjusted 40% reduction in mortality risk, P = 0.001) but not in the high RV pacing subgroup 
(adjusted HR = 0.89, P = 0.45). In addition, during the total 8 year follow up, high RV pacing 
was shown to be associated with a significant adjusted 40% (P = 0.01) increase in the risk of 
death  compared  with  low RV pacing  (Figure  1).  Thus,  the  long-term benefit  of  an  ICD in 
reducing mortality is prominent in patients with low RV pacing but attenuated in patients with 
high RV pacing, and patients with high versus low RV pacing have increased long term mortality 
risk.  A  reasonable  interpretation  of  these  findings  is  that  frequent  RV  pacing  resulted  in 
ventricular dyssynchrony, development and deterioration of HF which takes several years to be 
translated  into  increased  mortality.                                         
Figure 1: Probability of long-term mortality by percent of right ventricular pacing and ICD implantation in the 
MADIT  II  trial  with  extended  follow  up.  (reproduced  with  permission  of  the  publisher  [9])              
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The  Pathophysiology  of  RV  Apical  Pacing                                   
The deleterious effects of RV apical pacing have been attributed to the abnormal electrical and 
mechanical activation induced secondary to this form of pacing. During RV apical pacing, the 
electrical wave front propagates through the myocardium, rather than through the His-Purkinje 
conduction system. As a result, the electrical wave front propagates more slowly and induces 
heterogeneity  in electrical  activation of the myocardium, comparable but  not identical  to left 
bundle branch block. This is characterized by wave front breakthrough at the interventricular 
septum  and  latest  activation  at  the  infero-posterior  base  of  the  left  ventricle  [24-26].      
Similar to the changes in electrical activation of the ventricles, the mechanical activation pattern 
is altered during RV apical pacing. Importantly, not only does the anatomic onset of mechanical 
contraction differ, but also the resulting pattern of mechanical contraction [27]. Badke et al [28] 
detailed how apical  pacing is  associated with a diminished rate  of change in left  ventricular 
pressure (dP/dt) and an abnormal dyssynchronous contraction pattern. The paced region contract 
early at a time of low load, but then is stretched later in systole as the lateral wall finally contracts  
[28-29].  Hemodynamically,  asynchronous  myocardial  contraction  significantly  decreases  the 
stroke volume and right-shifts the left  ventricular end-systolic pressure - volume relationship. 
Mismatch between the relaxation of early- and late-contracting regions leads to a decrease in left  
ventricular filling time. Thus, RV apical pacing leads to ventricular dyssynchronization, systolic 
and diastolic ventricular dysfunction, increase in wall stress and energetic inefficiency [29].    
Beyond the hemodynamic effects of ventricular dyssynchrony, it has become clear that long-term 
RV pacing may also result in structural changes and adverse LV remodeling. Originally reported 
in1986 in  an  RV pacing  dog complete  heart  block  model  [30],  three  months  of  RV pacing 
resulted in myofibrillar disarray in 75% of these dogs. In cardiomyopathies induced by high-rate 
right ventricular apical pacing, they observed significant differences in the expression of proteins 
involved  in  myocyte  contraction,  which  were  not  seen  in  high-rate  atrial-pacing-induced 
cardiomyopathies with preserved ventricular synchrony [31]. The lateral left ventricular free wall 
(late-activated) displayed the most pronounced cellular derangements, such as down-regulation 
of protein kinases, proteins involved in calcium homeostasis and intercellular connections [31]. 
In addition, changes in LV wall thickness (the early activated wall becomes thinner whereas the 
late  activated  wall  becomes  thicker)  [17],  LV  remodeling  [32],  left  atrial  remodeling  [33], 
functional mitral regurgitation [34], and perfusion abnormalities [35-36] all appear to play a role 
in  the  pathophysiology of  RV apical  pacing;  predominately  as  downstream consequences  of 
iatrogenic  ventricular  dyssynchrony.                                   
RV  Pacing  and  QRS  morphology  at  implant                                     
It  has  long  been  known that  native  LBBB can  have  profound  hemodynamic  effects  due  to 
ventricular  dyssynchrony,  particularly  among  patients  with  HF  [37].  As  detailed  above, 
ventricular  pacing  contributes  to  the  development  or  exacerbation  of  HF  by  producing  an 
iatrogenic  form  of  LBBB  and  ventricular  dyssynchrony  reducing  systolic  and  diastolic 
ventricular  function.  Mechanical  activation  in  patients  with  chronic  RV  pacing  has  been 
compared to those with native LBBB, with patients from both groups having intraventricular 
dyssynchrony, but RV pacing patients displaying greater interventricular dyssynchrony and more 
often had sites  of earliest  activation from the apex and inferior  septum [38].                
We explored  the  effects  of  RV pacing  on ICD benefit  according  to  LBBB at  enrollment  in 
MADIT-II during an extended long term follow-up of 8 years [9]. We found that high RV pacing 
was associated with increased long term mortality only in patients who did not have LBBB at 
baseline (Figure 2).  Among patients without LBBB, high RV pacing was associated with an 
adjusted 63% (P = 0.002) increase in mortality risk compared with the low RV pacing subgroup, 
whereas among patients with LBBB there was no significant difference in mortality during long-
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 12 (3): 102-113 (2012)
Brenyo A et al, “Downside of Right Ventricular Apical Pacing”                                           107
term follow-up between high and low RV pacing patients (High vs. low RV pacing adjusted HR 
= 0.74,  p=0.343;  P value for  interaction [QRS morphology by RV pacing burden]  = 0.024). 
Consistent with our findings, Saad et al [39] showed in a small study (including 44 HF patients, 
12 with LBBB) that high RV pacing is associated with poor outcome only in the absence of 
LBBB. These findings may suggest that dyssynchrony induced by RV apical pacing is somewhat 
worse  than  naturally  occurring  LBBB dyssynchrony.  Alternatively,  these  findings  may  only 
suggest  that  RV pacing may not  be harmful  to patients  with  systolic  HF and LBBB, as  the 
incremental dyssynchrony induced by RV pacing is less significant.
Figure 2: Probability of long-term mortality by percent of right ventricular pacing in patients with LBBB (A) and 
without LBBB (B) in the MADIT II trial with extended follow up. (reproduced with permission of the publisher 
[9])
In  contrast  to these findings,  Hayes  et  al  [40]  in a substudy of the DAVID trial,  found that 
patients programmed to high pacing volume (DDD-70) with an abnormal QRS duration (≥110 
msec)  had  an  unadjusted  25% increased  risk  of  death  or  hospitalization  for  HF (p  = 0.01). 
Breaking down the abnormal QRS duration group into BBB morphologies, the adverse outcome 
for the group as a whole appeared to be driven by the LBBB patients (30%) that experienced an 
unadjusted  40%  increase  in  HF  or  death  (p  =  0.03).                           
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Reconciling the stark differences among these studies remains difficult. The primary differences 
between the MADIT-II  substudy and the DAVID substudy include different  study endpoints 
(death in MADIT II vs. HF or death in DAVID), duration of follow up and indication for pacing. 
DAVID specifically randomized patients based upon pacing programming where the focus of 
MADIT II was the efficacy of primary prevention ICD therapy in ischemic cardiomyopathy. 
Within the MADIT II sub-analysis the primary limitation was the clinical differences between 
high and low RV pacing subgroups. We cannot completely exclude the possibility that sicker 
patients required more pacing and had poorer outcomes as a result. Furthermore, data on percent 
RV pacing were collected only among 79% of the 720 patients who received an ICD in MADIT 
II.  Patients  who  were  not  included  in  this  data  analysis  due  to  missing  pacing  information 
appeared to be sicker with an elevated in-trial mortality rate of 42% compared with 12% in 
patients analyzed in our study. The DAVID analysis was limited by size and follow up duration. 
Minimizing the Detrimental  Effects  of  RV Pacing                                     
Methods to avoid the detrimental effects of RV pacing include device programming to minimize 
RV  pacing,  alternative  pacing  sites,  and  biventricular  pacing.  The  current  mainstay  of 
programming  based  methods  to  avoid  RV  pacing  includes  AV  search  or  MVP  (managed 
ventricular pacing) mode. Such programming was evaluated in the SAVE PACe (Search AV 
Extension and Managed Ventricular  Pacing for  Promoting Atrioventricular  Conduction)  trial, 
where  1,065  patients  with  sinus  node  disease  and  intact  AV  conduction  were  randomized 
between conventional dual-chamber pacing and dual-chamber minimal ventricular pacing [41]. 
RV pacing  burden  was  significantly  reduced  with  MVP,  compared  with  conventional  dual-
chamber ventricular pacing (9.1% vs. 99.0%, p < 0.001). After a mean follow-up of 1.7 years, the 
unadjusted  development  of  persistent  atrial  fibrillation  was  significantly  reduced  with  MVP 
(7.9% in minimal RV pacing vs. 12.7% in conventional dual-chamber pacing, p = 0.004). No 
significant  difference  in  HF  or  mortality  was  noted  with  MVP  programming.
When RV pacing is inevitable, the His bundle [42-43], right ventricular outflow tract [44-45] and 
right ventricular septum [46-47] have been studied as alternate pacing sites. Selectively pacing 
these sites may reduce pacing induced ventricular dyssynchrony [48-50] and potentially result in 
a reduction in ventricular volumes with improved LV function compared to RV apical pacing. 
However, with the small size, short term follow up and the absence of a reduction in HF or death 
within the randomized prospective studies,  the benefit  of  alternative  site  RV pacing remains 
controversial.  
For RV apical pacing dependent patients with abnormal LV function [51-56] or RV apical pacing 
associated  HF [57-58],  biventricular  pacing has  emerged  as  a  viable  option to  minimize the 
detrimental effects of RV pacing. Although some studies have demonstrated a clear long-term 
benefit of CRT over RV pacing with regard to peak VO2 or functional class [51,53], others have 
demonstrated only modest [54-55,57-58] or minimal benefit  [56].                             
The PACE trial [59] directly examined the efficacy of biventricular pacing within this population. 
Patients  post  biventricular  pacemakers  (177)  were  prospectively  enrolled  and  randomized  to 
receive  biventricular  pacing  (89  patients)  or  RV apical  pacing  (88  patients).  No  significant 
differences in LV ejection fraction (61.5 ± 6.6% for RV pacing, 61.9 ± 6.7 for biventricular 
pacing, p = 0.86) or LV end systolic volume (28.6 ± 10.7ml for RV pacing, 28.6 ± 9.4ml for 
biventricular pacing, p = 0.71) were present at baseline. At 12 months, the mean LV ejection 
fraction was significantly lower in the RV pacing group than in the biventricular-pacing group 
(54.8  ±  9.1%  vs.  62.2  ±  7.0%,  p  <  0.001).  Similarly,  the  LV  end-systolic  volume  was 
significantly higher in the RV pacing group than in the biventricular-pacing group (35.7 ± 16.3 
ml vs. 27.6 ± 10.4 ml, p < 0.001), with a relative change from baseline of 25% (p < 0.001).   
These results support the detrimental effect of RV apical pacing manifest through adverse LV 
remodeling and deterioration in LV function with such effects prevented by biventricular pacing.
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Conclusions
Right ventricular apical pacing is an integral part of the treatment of brady-arrhythmias for the 
majority of patients receiving pacemakers. Right ventricular apical pacing is, however, an often 
pathologic substitute for intrinsic ventricular activation over the His-Purkinje system. Several 
reports indicate that this form of pacing is detrimental potentially increasing the risk of heart 
failure episodes and death, particularly in patients with abnormal LV function. Further studies are 
needed to clarify the mechanisms underlying the deleterious effects of RV pacing, RV apical 
pacing burden to be avoided, and the specific risk factors for poor outcome among patients with 
high RV pacing burden. In the meantime, alternative pacemaker programming and configurations 
are available that can minimize the frequency and detrimental nature of ventricular pacing in 
many pacemaker patients.  Additional research will determine if different  forms of ventricular 
pacing, such as right ventricular outflow tract, RV septal pacing, or biventricular pacing will 
improve  outcomes  in  patients  who  require  ventricular  stimulation.                      
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